Regulation of Innovative Pharmaceuticals in the EU and the US

Abraham, John and Davis, Courtney (2005) Regulation of Innovative Pharmaceuticals in the EU and the US. Project Report. Economic and Social Research Council.

Full text not available from this repository.

Abstract

Combining theories of citizenship with documentary plus interview field methods, the proposed research will compare the regulation of innovative pharmaceuticals in the EU and the US from 1995 to 2000. It will do this: (i) by focusing on, and explaining, the inconsistencies in approvals/withdrawals of the same innovative pharmaceuticals between these European and American regulatory systems; and (ii) by considering how these regulatory systems can respond to recent, and potential future, challenges, such as the cost-effectiveness and appropriate therapeutic use of some new innovative pharmaceuticals, which command extensive medical and public demand, and the possible introduction of greater transparency and comparative effectiveness into regulatory agencies risk-benefit assessments of innovative pharmaceuticals

Item Type: Reports and working papers (Project Report)
Schools and Departments: School of Law, Politics and Sociology > Sociology
Depositing User: John Abraham
Date Deposited: 06 Feb 2012 20:01
Last Modified: 31 May 2013 14:36
URI: http://srodev.sussex.ac.uk/id/eprint/23561
📧 Request an update